Rett Syndrome
-
Treating core Rett syndrome symptoms
A new study published in Neurology reports the drug trofinetide has proven safe and effective in treating core symptoms of Rett syndrome in female children and adolescents. Read MoreJun 6, 2019
-
Drug discovery efforts may lead to new Rett syndrome treatments
Vanderbilt University research-ers have relieved symptoms of Rett syndrome in a mouse model with a small molecule that works like the dimmer switch in an electrical circuit. Read MoreAug 24, 2017
-
Rett syndrome expert Neul to speak at Kennedy Center on Friday
Jeffrey Neul, M.D., Ph.D., division head of Child Neurology and vice chair for Developmental Neurosciences at the University of California, San Diego, will present a lecture on Friday, Dec. 16, at Vanderbilt Kennedy Center (VKC). Read MoreDec 13, 2016
-
VUMC’s Rett Syndrome Clinic lands national recognition
Vanderbilt’s Rett Syndrome Clinic has been named a Rett Syndrome Clinical Research Center of Excellence by Rettsyndrome.org. Read MoreNov 17, 2016
-
Zoghbi to explore Rett Syndrome at upcoming Vanderbilt Prize Lecture
Huda Zoghbi, M.D., recipient of the 2015 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize Lecture on Thursday, April 21. Read MoreApr 14, 2016
-
Study reveals possible ‘dimmer switch’ drug for Rett syndrome
Researchers at Vanderbilt University Medical Center have relieved symptoms in a mouse model of Rett syndrome with a drug-like compound that works like the dimmer switch in an electrical circuit. Read MoreMar 3, 2016
-
Autism Speaks grant boosts Rett syndrome research
Colleen Niswender, Ph.D., research associate professor of Pharmacology, has received a three-year, $450,000 grant from the autism science and advocacy organization Autism Speaks to support studies investigating a possible new treatment for Rett syndrome. Read MoreJan 23, 2014